<p>Biofabrication and biomedical manufacturing are inherently multidisciplinary, integrating living systems with advanced manufacturing to create functional products for applications spanning regenerative engineering and medicine, in vitro disease modeling, drug discovery, and medical devices. As these technologies develop, they are emerging as core enablers of next-generation healthcare and life-science innovation. In the United States (U.S.), rapid progress across fabrication processes, material systems, physics-based modeling, and translation-oriented strategies is expanding the achievable design space and accelerating movement from laboratory demonstrations toward clinical and commercial deployment. We introduce major U.S. research frontiers and highlight representative advances in this field that support applications including organoids and other microphysiological systems for in vitro testing, engineered tissue constructs for in vivo use, and medical devices and biohybrid platforms. We further provide an outlook on advancing robust, ethical biofabrication and biomedical manufacturing in the U.S. research ecosystem.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Biofabrication and biomedical manufacturing research frontiers in the United States

  • Yunxia Chen,
  • Kyle R. Phillips,
  • Eben Alsberg,
  • Thomas E. Angelini,
  • Nasim Annabi,
  • Anthony Atala,
  • Amit Bandyopadhyay,
  • Leon M. Bellan,
  • Luiz E. Bertassoni,
  • Adriana Blazeski,
  • Thomas Boland,
  • Susmita Bose,
  • Jason A. Burdick,
  • Robert C. Chang,
  • Christopher S. Chen,
  • Roland K. Chen,
  • Douglas B. Chrisey,
  • Elizabeth Cosgriff-Hernandez,
  • Paul D. Dalton,
  • David Dean,
  • Aixiang Ding,
  • Bin Duan,
  • Marc Ferrer,
  • John P. Fisher,
  • Gabor Forgacs,
  • Debolina Ghosh,
  • Warren L. Grayson,
  • Murat Guvendiren,
  • MD Ahasan Habib,
  • Sarah C. Heilshorn,
  • Ashley Hicks,
  • Scott J. Hollister,
  • Congrui Jin,
  • Yifei Jin,
  • Roger D. Kamm,
  • Bashir Khoda,
  • Robert Langer,
  • Cato T. Laurencin,
  • Sang Jin Lee,
  • Kam W. Leong,
  • Ming C. Leu,
  • Wei Li,
  • Michael Mak,
  • Amir K. Miri,
  • Roger J. Narayan,
  • Liqun Ning,
  • Brenda M. Ogle,
  • Ibrahim T. Ozbolat,
  • Zhijian Pei,
  • Peihua Qiu,
  • Krishanu Saha,
  • Jayant Saksena,
  • Vahid Serpooshan,
  • Albert Shih,
  • Rohan A. Shirwaiker,
  • Pranav Soman,
  • Ali Tamayol,
  • Mark W. Tibitt,
  • Changxue Xu,
  • Yunzhi Peter Yang,
  • Lijie Grace Zhang,
  • James J. Yoo,
  • Shaochen Chen,
  • Yu Shrike Zhang,
  • Yong Huang

摘要

Biofabrication and biomedical manufacturing are inherently multidisciplinary, integrating living systems with advanced manufacturing to create functional products for applications spanning regenerative engineering and medicine, in vitro disease modeling, drug discovery, and medical devices. As these technologies develop, they are emerging as core enablers of next-generation healthcare and life-science innovation. In the United States (U.S.), rapid progress across fabrication processes, material systems, physics-based modeling, and translation-oriented strategies is expanding the achievable design space and accelerating movement from laboratory demonstrations toward clinical and commercial deployment. We introduce major U.S. research frontiers and highlight representative advances in this field that support applications including organoids and other microphysiological systems for in vitro testing, engineered tissue constructs for in vivo use, and medical devices and biohybrid platforms. We further provide an outlook on advancing robust, ethical biofabrication and biomedical manufacturing in the U.S. research ecosystem.